KR20080056774A - 요구에 따른 예방적 호르몬 피임 방법 - Google Patents

요구에 따른 예방적 호르몬 피임 방법 Download PDF

Info

Publication number
KR20080056774A
KR20080056774A KR1020087011824A KR20087011824A KR20080056774A KR 20080056774 A KR20080056774 A KR 20080056774A KR 1020087011824 A KR1020087011824 A KR 1020087011824A KR 20087011824 A KR20087011824 A KR 20087011824A KR 20080056774 A KR20080056774 A KR 20080056774A
Authority
KR
South Korea
Prior art keywords
progestogen
administered
transdermal patch
patch
daily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087011824A
Other languages
English (en)
Korean (ko)
Inventor
카린 슈미트-골-비처
귄터 스탁
Original Assignee
바이엘 쉐링 파마 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이엘 쉐링 파마 악티엔게젤샤프트 filed Critical 바이엘 쉐링 파마 악티엔게젤샤프트
Publication of KR20080056774A publication Critical patent/KR20080056774A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020087011824A 2005-10-19 2006-10-19 요구에 따른 예방적 호르몬 피임 방법 Ceased KR20080056774A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005050729.8 2005-10-19
DE102005050729A DE102005050729A1 (de) 2005-10-19 2005-10-19 Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption

Publications (1)

Publication Number Publication Date
KR20080056774A true KR20080056774A (ko) 2008-06-23

Family

ID=37762565

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087011824A Ceased KR20080056774A (ko) 2005-10-19 2006-10-19 요구에 따른 예방적 호르몬 피임 방법

Country Status (13)

Country Link
US (3) US20070111976A1 (https=)
EP (1) EP1937275A1 (https=)
JP (2) JP2009512658A (https=)
KR (1) KR20080056774A (https=)
CN (1) CN101340915A (https=)
BR (1) BRPI0617683A2 (https=)
CA (1) CA2626567C (https=)
CR (1) CR9908A (https=)
DE (1) DE102005050729A1 (https=)
EC (1) ECSP088390A (https=)
GT (1) GT200800038A (https=)
HN (1) HN2008000621A (https=)
WO (1) WO2007045513A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"
US20120129825A1 (en) * 2009-04-14 2012-05-24 Andre Ulmann Method for on-demand contraception using levonorgestrel or norgestrel
RS55331B1 (sr) * 2009-04-14 2017-03-31 Hra Pharma Lab Postupak za kontracepciju po potrebi
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US9579330B2 (en) 2012-11-22 2017-02-28 Bayer Pharma Aktiengesellschaft Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9655887B2 (en) 2013-05-23 2017-05-23 Bayer Pharma Aktiengesellschaft Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
IL115738A (en) * 1994-10-24 2002-05-23 Schering Ag Competitive progesterone antagonists for regulating female fertility as required
UA77150C2 (en) * 1999-08-31 2006-11-15 Schering Ag Use of mesoprogestins j867, j912, or j1042 for female contraception, pharmaceutical composition and kit (variants)
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
WO2003093322A2 (en) * 2002-04-30 2003-11-13 The Population Council, Inc. Carrageenan based antimicrobial compositions
CA2549916C (en) * 2003-12-12 2013-09-17 Schering Aktiengesellschaft Transdermal delivery system of hormones without penetration enhancers
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene

Also Published As

Publication number Publication date
CA2626567C (en) 2013-12-03
US20080311180A1 (en) 2008-12-18
GT200800038A (es) 2009-04-01
WO2007045513A1 (de) 2007-04-26
BRPI0617683A2 (pt) 2011-08-02
JP2014001239A (ja) 2014-01-09
JP2009512658A (ja) 2009-03-26
CA2626567A1 (en) 2007-04-26
DE102005050729A1 (de) 2007-04-26
US20130089574A1 (en) 2013-04-11
EP1937275A1 (de) 2008-07-02
CR9908A (es) 2008-05-21
US20070111976A1 (en) 2007-05-17
CN101340915A (zh) 2009-01-07
HN2008000621A (es) 2011-07-22
ECSP088390A (es) 2008-05-30

Similar Documents

Publication Publication Date Title
US20130089574A1 (en) Method of preventive on-demand hormonal contraception
US10500215B2 (en) Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
US5762956A (en) Transdermal contraceptive delivery system and process
PL188009B1 (pl) Plaster przezskóry typu osnowy do współpodawania estradiolu i innego steroidu oraz jego zastosowanie
US7871995B2 (en) Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
KR100758757B1 (ko) 개량된 경피적 피임제 송달시스템 및 송달방법
HUP0102785A2 (hu) Matrix típusú, transzdermális hatóanyag-szolgáltató rendszer szteroid hormonok felszabadítására
WO2011000210A1 (zh) 促渗剂组合物及其透皮给药系统中的应用
EP0600873B1 (en) Therapeutically effective topical application of st1435
Christin-Maitre Use of hormone replacement in females with endocrine disorders
KR100795870B1 (ko) 라소폭시펜의 경피적 송달
JP3043071B2 (ja) エストロゲンを含む経皮的投与装置
TW474826B (en) New devices intended for the transdermic administration of trimegestone, their preparation process and their use as medicaments
JPH09508911A (ja) デソゲストレルを含有する経皮適用剤
HK1126413A (en) Method of preventive on-demand hormonal contraception
Ibarra de Palacios et al. Comparative study to evaluate skin irritation and adhesion of Estradot® and Climara® in healthy postmenopausal women
WO1995001161A1 (en) Pack for use in, and method of hormonal replacement therapy
BG106443A (bg) Мезопрогестини (прогестерон рецептор модулатори) като компонент на състави за хормонозаместваща терапия
Diczfalusy Patch up the Menopause
EP0675720A1 (en) Transdermal, multiphasic hormone replacement therapy

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080516

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20111019

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130328

Patent event code: PE09021S01D

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20130617

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20140221

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130328

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I